Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITA.
Olbrich P, Fischer M, Deyà-Martinez A, Campos-Asensio C, Neth O, Hadjadj J, Forbes Satter LR, Leiding JW, Torgerson TR, Bakhtiar S, Baris S, Badolato R, Bloomfield M, Buddingh EP, Burroughs LM, Burns S, Cooper MA, Crickx E, Ehl S, Farmand S, Freeman AF, Gonzalez-Granado LI, Hagin D, Hanitsch LG, Hanzlikova J, Hauck F, Ivorra-Cortés J, Körholz J, Lankester AC, Leahy TR, Meyts I, Milner JD, Nademi Z, Pachlopnik Schmid J, Pergent M, Prévot J, Rivière JG, Roxo-Junior P, Schuetz C, Slatter MA, Soler Palacín P, Warnatz K, Vítovcová P, Vastert SJ, Neven B, Albert MH, Speckmann C; Inborn Errors Working Party of ESID/EBMT and the European Reference Network RITA.
Olbrich P, et al. Among authors: leahy tr.
J Allergy Clin Immunol. 2026 May 26:S0091-6749(26)00343-X. doi: 10.1016/j.jaci.2026.05.005. Online ahead of print.
J Allergy Clin Immunol. 2026.
PMID: 42203177